04/25/2025
3:31 PM | Aquestive Therapeutics (Filer)
| Form DEF 14A | |
04/25/2025
3:33 PM | Aquestive Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025
3:34 PM | Aquestive Therapeutics (Filer)
| Form ARS | |
04/01/2025
7:26 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2025
4:47 PM | Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
4:47 PM | Aquestive Therapeutics (Issuer)
Boyd Peter E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
4:47 PM | Aquestive Therapeutics (Issuer)
BRAENDER LORI J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
4:48 PM | Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
4:48 PM | Aquestive Therapeutics (Issuer)
Kraus Carl N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
4:48 PM | Aquestive Therapeutics (Issuer)
TOTH A ERNEST JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
4:48 PM | Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AQST and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aquestive Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/11/2025
4:49 PM | Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
7:10 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
3:29 PM | Aquestive Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
5:12 PM | Aquestive Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/13/2025
10:38 AM | Aquestive Therapeutics (Subject)
BRATTON DOUGLAS K (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025
6:22 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
3:51 PM | Aquestive Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/13/2025
6:07 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
7:02 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
7:08 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
3:40 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
3:42 PM | Aquestive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/25/2024
7:05 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
7:06 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/22/2024
5:06 PM | Aquestive Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
10/16/2024
4:16 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
1:14 PM | Aquestive Therapeutics (Issuer)
Jung Cassie (Reporting)
| Form 4/A | |
10/02/2024
1:15 PM | Aquestive Therapeutics (Issuer)
Barber Daniel (Reporting)
| Form 4/A | |
10/02/2024
1:15 PM | Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
| Form 4/A | |
10/02/2024
1:16 PM | Aquestive Therapeutics (Issuer)
Schobel Alexander Mark (Reporting)
| Form 4/A | |
09/27/2024
7:46 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
7:56 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:08 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
1:45 PM | Aquestive Therapeutics (Issuer)
Kraus Carl N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:26 PM | Aquestive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/25/2024
7:16 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
3:32 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
12:51 PM | Aquestive Therapeutics (Issuer)
MORRIS TIMOTHY E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
12:50 PM | Aquestive Therapeutics (Issuer)
COSTA SANTO J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
12:50 PM | Aquestive Therapeutics (Issuer)
Cochran John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad) $2 trillion has disappeared from the US government's books.
The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth. Click here to see his new research now. |
06/21/2024
12:50 PM | Aquestive Therapeutics (Issuer)
Krop Julie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
12:51 PM | Aquestive Therapeutics (Issuer)
BROWN GREGORY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
12:51 PM | Aquestive Therapeutics (Issuer)
Taglietti Marco (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
4:14 PM | Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
| Form 3/A | |
06/11/2024
11:35 AM | Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/11/2024
11:36 AM | Aquestive Therapeutics (Issuer)
Korczynski Sherry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
7:13 AM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
12:40 PM | Aquestive Therapeutics (Issuer)
Jenkins Abigail L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
12:40 PM | Aquestive Therapeutics (Issuer)
Wargacki Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
8:08 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:21 PM | Aquestive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:23 PM | Aquestive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Buy AQST Stock Free AQST Stock Alerts